Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425697 · ClinicalTrials.gov registry record · NA
Eliminate Risk of Cardiac Surgical Site Events
A NA study of Surgical Site Infections, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 739
- Enrollment target
- 4
- Study locations
NCT01425697: Completed NA study of Surgical Site Infections, sponsored by University of Rochester.
NCT01425697 is a NA study of Surgical Site Infections that has completed, run by University of Rochester. The registered enrollment target is 739 participants, below the 1,641-participant average among 3 other Surgical Site Infections trials with a reported enrollment target (55% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01425697, a NA study of Surgical Site Infections, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 739 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the study is to see if using 2% Chlorhexidine cloths will reduce surgical site infections in patients having elective cardiac surgery.
Primary Outcome
Subjects will be assessed at 30 days and 90 days post operatively for any surgical site infection
Conditions Studied
Interventions
- OTHER 2% Chlorhexidine Gluconate cloths
- OTHER Standard of Care preoperative preparation.
Study Locations (4)
Kentucky
- University of Kentucky - Lexington
New Jersey
- The Valley Hospital - Ridgewood
New York
- University of Rochester Medical Center - Rochester
Pennsylvania
- Robert Packer Hospital - Sayre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 739 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01425697 record still lists
NCT01425697 is an interventional study that assigns participants to a tested intervention. The registered 739 participants enrollment target is mid-sized for trials with a published cap, below the 1,641-participant average among 3 other Surgical Site Infections trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Surgical Site Infections appearing as the primary indexed condition, and to 2 interventions - of which 2% Chlorhexidine Gluconate cloths is the first listed.
NCT01425697 reports a single indexed study location in Kentucky, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT01425697 about?
NCT01425697 is a clinical study titled "Eliminate Risk of Cardiac Surgical Site Events". The purpose of the study is to see if using 2% Chlorhexidine cloths will reduce surgical site infections in patients having elective cardiac surgery.
What is the current status of trial NCT01425697?
This trial is currently completed. It is a NA study. The enrollment target is 739 participants. The study started on 2008-11. Estimated completion is 2012-09.
What conditions does trial NCT01425697 study?
This clinical trial studies the following conditions: Surgical Site Infections.
What interventions are being tested in trial NCT01425697?
The interventions under investigation include: 2% Chlorhexidine Gluconate cloths (OTHER), Standard of Care preoperative preparation. (OTHER).
Who is sponsoring clinical trial NCT01425697?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01425697 being conducted?
This trial has 4 study locations across Kentucky, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Site Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
RECRUITING
-
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
RECRUITING · Phase 3
-
2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03723928 · 739 participants · NA
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- NCT03963622 · 740 participants · NA
Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
- NCT04074135 · 740 participants · Phase 2
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
- NCT05215340 · 740 participants · Phase 3
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia